TNFSF13B and Miyoshi myopathy: Our results provide evidence that patients with active MM have raised BAFF, IL-6, IL-10, and IL-15 serum levels as well high Ki-67 expression of plasma cells in the bone marrow, whereas those of the posttreatment experience a significant reduction of these factors.